产品编号：K202056
产品规格：10mg
产品价格：面议
| 标准品编号: | K202056 |
| 名称: | 15-Keto Prostaglandin E0 Dicyclohexylammonium Salt |
| 别名: | (11α)-11-Hydroxy-9,15-dioxo-prostan-1-oic Acid Dicyclohexylammonium salt; 3-Hydroxy-5-oxo-2-(3-oxooctyl)-cyclopentaneheptanoic Acid Dicyclohexylammonium salt; 3-Hydroxy-5-oxo-2-(3-oxooctyl)-cyclopentaneheptanoic Acid Stereoisomer Dicyclohexylammonium salt; 11α-Hydroxy-9,15-diketoprostanoic Acid Dicyclohexylammonium salt; 11α-Hydroxy-9,15-dioxoprostanoic Acid Dicyclohexylammonium salt; 13,14-Dihydro-15-keto-PGE1 Dicyclohexylammonium salt; 13,14-Dihydro-15-keto-PGE1 Dicyclohexylammonium salt; 13,14-Dihydro-15-ketoprostaglandin E1 Dicyclohexylammonium salt; 13,14-Dihydro-15-oxo-PGE1 Dicyclohexylammonium salt; 15-Oxodihydroprostaglandin E1 Dicyclohexylammonium salt; 15-keto-13,14-Dihydro-PGE1 Dicyclohexylammonium salt; 15-keto-13,14-Dihydroprostaglandin E1 Dicyclohexylammonium salt; Dihydro |
| 参考CAS号: | 5094-14-4 |
| 分子式: | C₂₀H₃₄O₅ • C₁₂H₂₃N |
| 分子量: | 354.4818132 |
| 种类: | Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites; Lipids/Fatty Acids, Glycerol Derivatives; |
| 应用: | 15-Keto Prostaglandin E0 is a metabolite of Prostaglandin E1 (P838600) and has been shown to induce arterial thromboresistance in experimental animals and in man, but with several magnitudes higher concentrations than Prostaglandin E1. 15-Keto Prostaglandin E0 is also used as the active ingredient in compositions used for the treatment of external secretion disorders. |
| 参考文献 | |
